{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:22:18Z","timestamp":1783444938131,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Clinical Practice"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ctcp.2019.101072","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T02:28:10Z","timestamp":1573612090000},"page":"101072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Melatonin in the treatment of fibromyalgia symptoms: A systematic review"],"prefix":"10.1016","volume":"38","author":[{"given":"Karim","family":"Hemati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azade","family":"Amini Kadijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sayehmiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Mehrzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhdeh","family":"Zabihiyeganeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ctcp.2019.101072_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF01923948","article-title":"The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates","volume":"49","author":"Huether","year":"1993","journal-title":"Experientia"},{"issue":"16","key":"10.1016\/j.ctcp.2019.101072_bib2","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","article-title":"Extrapineal melatonin: sources, regulation, and potential functions","volume":"71","author":"Acu\u00f1a-Castroviejo","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ctcp.2019.101072_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF03168221","article-title":"Physiological and metabolic functions of melatonin","volume":"60","author":"Barrenetxe","year":"2004","journal-title":"J. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.ctcp.2019.101072_bib4","first-page":"194","article-title":"Melatonin in aging and disease\u2014multiple consequences of reduced secretion, options and limits of treatment","volume":"3","author":"Hardeland","year":"2012","journal-title":"Aging Dis."},{"key":"10.1016\/j.ctcp.2019.101072_bib5","doi-asserted-by":"crossref","DOI":"10.4103\/1735-1995.199092","article-title":"Melatonin and human mitochondrial diseases","volume":"22","author":"Sharafati-Chaleshtori","year":"2017","journal-title":"J. Res. Med. Sci."},{"issue":"16","key":"10.1016\/j.ctcp.2019.101072_bib6","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1111\/bph.13898","article-title":"Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes","volume":"175","author":"Jahanban-Esfahlan","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ctcp.2019.101072_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2017.12.001","article-title":"Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress","volume":"193","author":"Dehdashtian","year":"2018","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.ctcp.2019.101072_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-8749.1994.tb11818.x","article-title":"The treatment of sleep disorders with melatonin","volume":"36","author":"Jan","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"10.1016\/j.ctcp.2019.101072_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1468-1331.2006.01132.x","article-title":"Influence of melatonin on fatigue severity in patients with chronic fatigue syndrome and late melatonin secretion","volume":"13","author":"Van Heukelom","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.ctcp.2019.101072_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/157015912800604489","article-title":"Melatonin in antinociception: its therapeutic applications","volume":"10","author":"Srinivasan","year":"2012","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.ctcp.2019.101072_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4103\/2230-8210.98051","article-title":"Melatonin: miracles far beyond the pineal gland","volume":"16","author":"Afzal","year":"2012","journal-title":"Indian J Endocrinol. Metab"},{"key":"10.1016\/j.ctcp.2019.101072_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14196\/mjiri.32.29","article-title":"Effects of vitamin D optimization on quality of life of patients with fibromyalgia: a randomized controlled trial","volume":"32","author":"Mirzaei","year":"2018","journal-title":"Med. J. Islam. Repub. Iran"},{"issue":"15","key":"10.1016\/j.ctcp.2019.101072_bib13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ctcp.2019.101072_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.genhosppsych.2019.01.003","article-title":"The effect of cognitive behavioral therapy on the circulating proinflammatory cytokines of fibromyalgia patients: a pilot controlled clinical trial","volume":"57","author":"Zabihiyeganeh","year":"2019","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"7","key":"10.1016\/j.ctcp.2019.101072_bib15","first-page":"1589","article-title":"Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study","volume":"30","author":"Andrianakos","year":"2003","journal-title":"J Rheumatol."},{"issue":"9","key":"10.1016\/j.ctcp.2019.101072_bib16","first-page":"806","article-title":"Fibromyalgia prevalence in Tunisia","volume":"86","author":"Guermazi","year":"2008","journal-title":"Tunis. Med."},{"issue":"8","key":"10.1016\/j.ctcp.2019.101072_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr. Pain Headache Rep."},{"issue":"2","key":"10.1016\/j.ctcp.2019.101072_bib18","first-page":"133","article-title":"Understanding fibromyalgia and its related disorders","volume":"10","author":"Goldenberg","year":"2008","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.ctcp.2019.101072_bib19","article-title":"Oxidative stress and mitochondrial dysfunction in fibromyalgia","volume":"31","author":"Cordero","year":"2010","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.ctcp.2019.101072_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/JPR.S128508","article-title":"Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma","volume":"10","author":"B\u00e4ckryd","year":"2017","journal-title":"J. Pain Res."},{"issue":"4","key":"10.1016\/j.ctcp.2019.101072_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11916-001-0023-0","article-title":"Nociceptive aspects of fibromyalgia","volume":"5","author":"Larson","year":"2001","journal-title":"Curr. Pain Headache Rep."},{"issue":"75","key":"10.1016\/j.ctcp.2019.101072_bib22","first-page":"38","article-title":"Is fibromyalgia a neuropathic pain syndrome?","volume":"32","author":"Rowbotham","year":"2005","journal-title":"J. Rheumatol. Suppl."},{"issue":"1","key":"10.1016\/j.ctcp.2019.101072_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.32794\/mr11250011","article-title":"Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells","volume":"2","author":"Tan","year":"2019","journal-title":"Melatonin Res."},{"issue":"3","key":"10.1016\/j.ctcp.2019.101072_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/ijms20030765","article-title":"Mitochondrial dysfunction in skeletal muscle of a fibromyalgia model: the potential benefits of melatonin","volume":"20","author":"Favero","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1 Suppl 88","key":"10.1016\/j.ctcp.2019.101072_bib25","first-page":"S14","article-title":"The involvement of melatonin in the clinical status of patients with fibromyalgia syndrome","volume":"33","author":"Pernambuco","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"10.1016\/j.ctcp.2019.101072_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ctcp.2019.101072_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ctcp.2019.101072_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s100670050003","article-title":"The effect of melatonin in patients with fibromyalgia: a pilot study","volume":"19","author":"Citera","year":"2000","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.ctcp.2019.101072_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2050-6511-15-40","article-title":"Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial","volume":"15","author":"de Zanette","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.ctcp.2019.101072_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jab.2018.01.005","article-title":"Oral melatonin administration improves the objective and subjective sleep quality, increases 6-sulfatoxymelatonin levels and total antioxidant capacity in patients with fibromyalgia","volume":"16","author":"Casta\u00f1o","year":"2018","journal-title":"J. Appl. Biomed."},{"issue":"3","key":"10.1016\/j.ctcp.2019.101072_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-079X.2010.00836.x","article-title":"Adjuvant use of melatonin for treatment of fibromyalgia","volume":"50","author":"Hussain","year":"2011","journal-title":"J. Pineal Res."},{"issue":"5","key":"10.1016\/j.ctcp.2019.101072_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063773","article-title":"Meta-analysis: melatonin for the treatment of primary sleep disorders","volume":"8","author":"Ferracioli-Oda","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ctcp.2019.101072_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40266-014-0178-0","article-title":"Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature","volume":"31","author":"Vural","year":"2014","journal-title":"Drugs Aging"},{"issue":"11\u201312","key":"10.1016\/j.ctcp.2019.101072_bib34","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.exger.2004.04.012","article-title":"Melatonin, human aging, and age-related diseases","volume":"39","author":"Karasek","year":"2004","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.ctcp.2019.101072_bib35","article-title":"The effect of long-term melatonin supplementation on psychosomatic disorders in postmenopausal women","volume":"69","author":"Chojnacki","year":"2018","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ctcp.2019.101072_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2013.12.021","article-title":"Serum melatonin is an alternative index of Parkinson's disease severity","volume":"1547","author":"Lin","year":"2014","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.ctcp.2019.101072_bib37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/eci.10.64","article-title":"Duloxetine for the treatment of fibromyalgia","volume":"6","author":"Wright","year":"2010","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.ctcp.2019.101072_bib38","first-page":"99","article-title":"Duloxetine for the management of fibromyalgia syndrome","volume":"2","author":"Scholz","year":"2009","journal-title":"J. Pain Res."}],"container-title":["Complementary Therapies in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744388119308059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744388119308059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:49:33Z","timestamp":1761677373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744388119308059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":38,"alternative-id":["S1744388119308059"],"URL":"https:\/\/doi.org\/10.1016\/j.ctcp.2019.101072","relation":{},"ISSN":["1744-3881"],"issn-type":[{"value":"1744-3881","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin in the treatment of fibromyalgia symptoms: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctcp.2019.101072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101072"}}